Ironwood Pharma (IRWD) Tops Q1 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/5/2026

1. AMD
2. BKNG
3. AMGN
4. DOX
5. DUOL
6. ANET
7. CVS
8. SWKS
9. SPY
10. XYZ

Go back to Ironwood Pharma (IRWD) Tops Q1 EPS by 6c

Ironwood Pharmaceuticals Provides First Quarter 2016 Investor Update

May 9, 2016 4:05 PM EDT

Progress across priority opportunities, including two Phase IIb trials underway, and lesinurad license establishes new uncontrolled gout franchise

LINZESS® (linaclotide) U.S. net sales increased ~44% to $137 million in 1Q 2016 compared to 1Q 2015; on track to exceed $1 billion in net sales by 2020

Ironwood revenue increased 128% to $66 million in 1Q 2016, primarily driven by continued growth in LINZESS net sales and profitability; Ironwood on track to achieve positive cash flow in 2018

CAMBRIDGE, Mass.--(BUSINESS WIRE)--... More